English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
you are here:

HDFC Pharma and Healthcare Fund - Regular Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : HDFC Mutual Fund
  • NAV
    : ₹ 17.651 0.9%
    (as on 19th September, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Fund Size
: ₹ 1909.3 Cr
(0.38% of Investment in Category)
 Expense Ratio
: 2.08%
(2.12% Category average)
Risk-O-Meter
Very High Risk

The fund has 98.89% investment in domestic equities of which 31.98% is in Large Cap stocks, 17.47% is in Mid Cap stocks, 10.95% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
₹
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 19th September, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 12-Sep-25 10119.20 1.19% - 1.37% 144/239
1 Month 19-Aug-25 10153.60 1.54% - 2.27% 160/237
3 Month 19-Jun-25 10860.10 8.60% - 5.23% 38/229
6 Month 19-Mar-25 11189.90 11.90% - 14.18% 151/225
YTD 01-Jan-25 10330.10 3.30% - 3.97% 110/214
1 Year 19-Sep-24 11056.10 10.56% 10.56% -0.61% 10/192
Since Inception 04-Oct-23 17713.00 77.13% 33.84% 13.03% 2/218
Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 19th September, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 19-Sep-24 12000 13026.91 8.56 % 16.18 %
SIP Calculator Detailed Returns Analysis
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Portfolio Turnover Ratio : 33.07%  |   Category average turnover ratio is 154.05%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 98.89% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 98.89%
No of Stocks : 29 (Category Avg - 44.44) | Large Cap Investments : 31.98%| Mid Cap Investments : 17.47% | Small Cap Investments : 10.95% | Other : 38.49%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 1984.6 10.39% -0.58% 14.02% (Oct 2024) 10.39% (Aug 2025) 12.45 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 1584.9 8.30% -0.51% 10.24% (May 2025) 7.18% (Dec 2024) 2.58 L 0.00
Glenmark Pharmaceuticals Ltd. Pharmaceuticals 1294.4 6.78% -0.64% 7.42% (Jul 2025) 2.84% (Sep 2024) 6.73 L 0.00
Lupin Ltd. Pharmaceuticals 1285.3 6.73% 0.75% 6.73% (Aug 2025) 5.32% (Sep 2024) 6.78 L 78.55 k
Cipla Ltd. Pharmaceuticals 1253 6.56% 0.23% 8.17% (Oct 2024) 5.48% (Sep 2024) 7.88 L 0.00
Ipca Laboratories Ltd. Pharmaceuticals 882.2 4.62% 0.25% 4.62% (Aug 2025) 3.26% (Jan 2025) 6.37 L 62.77 k
Alkem Laboratories Ltd. Pharmaceuticals 751.4 3.94% 0.95% 3.94% (Aug 2025) 0% (Sep 2024) 1.42 L 26.50 k
Torrent Pharmaceuticals Ltd. Pharmaceuticals 714.1 3.74% -0.14% 3.88% (Jul 2025) 2.26% (Oct 2024) 2.01 L 0.00
Krishna Institute of Medical Sciences Ltd. Hospital 712.8 3.73% -0.09% 4.04% (Mar 2025) 3.25% (Oct 2024) 9.85 L 0.00
Laurus Labs Ltd. Pharmaceuticals 691 3.62% -0.02% 3.64% (Jul 2025) 0% (Sep 2024) 8.06 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Detailed Portfolio Analysis
Name Type of Instrument Weight (%)
TREPS TREPS 1.03%
Net Receivables Net Receivables 0.08%
Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)

    No data available. Ratios are only available for the funds which are 3 years old.

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 389.09 11.12 30.65 54.87 46.98 33.53
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 249.75 3.99 11.91 17.77 26.31 18.55
Franklin Asian Equity Fund - Growth NA 259.99 5.92 13.00 16.09 18.21 12.73
Motilal Oswal Business Cycle Fund - Regular Plan - Growth NA 1976.19 4.99 9.24 15.05 17.81 0.00
Nippon India Japan Equity Fund - Growth NA 283.56 1.67 10.25 13.77 16.38 17.74
Nippon India US Equity Opportunities Fund - Growth NA 713.51 3.56 7.49 10.70 15.32 19.93
Motilal Oswal Manufacturing Fund - Regular Plan - Growth NA 786.43 7.55 9.77 22.45 11.37 0.00
HDFC Transportation and Logistics Fund - Regular Plan - Growth NA 1533.43 6.37 21.68 34.77 11.35 0.00
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 8370.76 0.28 2.83 15.38 10.43 17.86
WhiteOak Capital Pharma and Healthcare Fund - Regular Plan - Growth NA 423.51 0.38 8.63 12.21 10.09 0.00

More Funds from HDFC Mutual Fund

Out of 123 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 6 is/are ranked 4 * , 22 is/are ranked 3 * , 3 is/are ranked 2 * , 1 is/are ranked 1 * , and 88 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
HDFC Balanced Advantage Fund - Growth 4 101079.60 1.53 2.20 8.93 3.09 18.86
HDFC Mid Cap Fund - Growth 4 83104.83 2.19 5.19 16.83 3.59 25.56
HDFC Flexi Cap Fund - Growth 4 81935.61 2.12 5.20 13.98 6.51 22.89
HDFC Liquid Fund - Growth 3 63201.14 0.47 1.42 3.27 6.83 6.96
HDFC Large Cap Fund - Growth 3 37659.18 1.21 3.28 9.95 -2.55 16.65
HDFC Large Cap Fund - Growth 3 37659.18 1.65 3.32 11.79 -0.34 14.23
HDFC Small Cap Fund - Growth 3 36294.07 2.35 8.15 23.95 2.97 23.56
HDFC Money Market Fund - Growth 2 36065.96 0.46 1.49 4.03 7.76 7.44
HDFC Corporate Bond Fund - Growth 3 35821.39 0.42 0.82 4.10 7.66 7.64
HDFC Large and Mid Cap Fund - Regular - Growth 3 26157.98 2.10 4.36 14.73 -0.39 20.71
All funds

Forum

POST

+ See More

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347